Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Carrageenin
2. Iota Carrageenan
3. Iota-carrageenan
4. Kappa Carrageenan
5. Kappa-carrageenan
6. Lambda Carrageenan
7. Lambda-carrageenan
1. 9000-07-1
2. Zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate
3. Carrageenan, Native
4. Miv-150/za/cg
5. Miv-150/zinc Acetate Carrageenan
6. Zinc 1-(5-cyano-2-pyridyl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoyl-phenyl)cyclopropyl]urea Diacetate
1. Kappa-carrageenan
2. Carrageenan Api
| Molecular Weight | 551.8 g/mol |
|---|---|
| Molecular Formula | C23H23FN4O7Zn |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 5 |
| Exact Mass | 550.084219 g/mol |
| Monoisotopic Mass | 550.084219 g/mol |
| Topological Polar Surface Area | 195 Ų |
| Heavy Atom Count | 36 |
| Formal Charge | 0 |
| Complexity | 647 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 4 |
Traditional Medicine: ... Used in tuberculosis, coughs, bronchitis, and intestinal problems, usually in the form of a decoction of the seaweed.
Leung, A.Y., Foster, S. Encyclopedia of Common Natural Ingredients Used in Food, Drugs, and Cosmetics. New York, NY. John Wiley & Sons, Inc. 1996., p. 126
Carrageenan, both in the degraded (molecular weight greater than or equal to 20,000) and undegraded forms, has been reported to alleviate peptic and duodenal ulcers in humans.
Leung, A.Y., Foster, S. Encyclopedia of Common Natural Ingredients Used in Food, Drugs, and Cosmetics. New York, NY. John Wiley & Sons, Inc. 1996., p. 125
IN GUINEA-PIGS, NATIVE FORM OF CARRAGEENAN WAS NOT ABSORBED; DEGRADED CARRAGEENAN COULD NOT BE DETECTED IN URINE OF ANIMALS @ LEVELS OF ABOUT 0.3 MG/ML AFTER 1.85 G HAD BEEN ADMIN IN DRINKING-WATER OR @ LEVELS OF BETWEEN 0.03-0.3 MG/ML WHEN 4-15 MG/KG BODY WT OF DEGRADED CARRAGEENAN HAD BEEN ADMIN IV.
IARC. Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Geneva: World Health Organization, International Agency for Research on Cancer, 1972-PRESENT. (Multivolume work). Available at: https://monographs.iarc.fr/ENG/Classification/index.php, p. V10 186 (1976)
NATIVE CARRAGEENAN FED TO YOUNG RATS @ LEVELS OF 2-20% IN DIET WAS FOUND TO BE EXCRETED QUANTITATIVELY IN FECES.
IARC. Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Geneva: World Health Organization, International Agency for Research on Cancer, 1972-PRESENT. (Multivolume work). Available at: https://monographs.iarc.fr/ENG/Classification/index.php, p. V10 186 (1976)
NO STORAGE OF CARRAGEENAN WAS FOUND IN RHESUS MONKEYS GIVEN 1% NATIVE CARRAGEENAN IN DRINKING-WATER OVER 7-11 WEEKS, FOLLOWED BY 24-WK RECOVERY PERIOD. IN CONTRAST, DEGRADED CARRAGEENAN, WHICH WAS RETAINED AFTER ABSORPTION IN RETICULOENDOTHELIAL TISSUE, COULD STILL BE FOUND IN KUPFFER CELLS 6 MONTHS AFTER ADMIN.
IARC. Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Geneva: World Health Organization, International Agency for Research on Cancer, 1972-PRESENT. (Multivolume work). Available at: https://monographs.iarc.fr/ENG/Classification/index.php, p. V10 186 (1976)
Carrageen has inhibitory effects on pepsin activity in vitro. Its degraded form (no viscosity) and forms with low and high viscosities all exhibit antiproteolytic activities in vitro against papain.
Leung, A.Y., Foster, S. Encyclopedia of Common Natural Ingredients Used in Food, Drugs, and Cosmetics. New York, NY. John Wiley & Sons, Inc. 1996., p. 125
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Market Place
ABOUT THIS PAGE
A Carrageenan API manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Carrageenan API, including repackagers and relabelers. The FDA regulates Carrageenan API manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Carrageenan API API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Carrageenan API supplier is an individual or a company that provides Carrageenan API active pharmaceutical ingredient (API) or Carrageenan API finished formulations upon request. The Carrageenan API suppliers may include Carrageenan API API manufacturers, exporters, distributors and traders.
click here to find a list of Carrageenan API suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Carrageenan API DMF (Drug Master File) is a document detailing the whole manufacturing process of Carrageenan API active pharmaceutical ingredient (API) in detail. Different forms of Carrageenan API DMFs exist exist since differing nations have different regulations, such as Carrageenan API USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Carrageenan API DMF submitted to regulatory agencies in the US is known as a USDMF. Carrageenan API USDMF includes data on Carrageenan API's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Carrageenan API USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Carrageenan API suppliers with USDMF on PharmaCompass.
Carrageenan API Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Carrageenan API GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Carrageenan API GMP manufacturer or Carrageenan API GMP API supplier for your needs.
A Carrageenan API CoA (Certificate of Analysis) is a formal document that attests to Carrageenan API's compliance with Carrageenan API specifications and serves as a tool for batch-level quality control.
Carrageenan API CoA mostly includes findings from lab analyses of a specific batch. For each Carrageenan API CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Carrageenan API may be tested according to a variety of international standards, such as European Pharmacopoeia (Carrageenan API EP), Carrageenan API JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Carrageenan API USP).
LOOKING FOR A SUPPLIER?
